Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Nomic is not a typical general-purpose enterprise SaaS product, but a combination of proteomics testing services and a data analysis platform. Its flagship product, Omni 1000, is positioned around the “$50 Proteome”: quantifying 1,000 high-information proteins at a relatively low cost. The underlying technology is nELISA, which uses DNA as a programmable linker to expand the multiplexing capabilities of sandwich immunoassays. The site says it has analyzed 950,000+ samples and supports 150+ organizations, making its positioning clearly geared toward life sciences and drug discovery use cases.
The product line includes Omni 1000, Omni 1000 Core, and Flex. Omni 1000 covers 1,000 proteins and provides absolute quantification; Core is a context-specific panel of around 300 proteins; and Flex allows users to select markers from the full protein library to build custom panels on demand. The platform emphasizes high sensitivity, 99.99% specificity, <10% intra-plate CV, a 3–6 log dynamic range, and high-throughput capacity of tens of thousands of samples per week. The copy also mentions analytics tools that turn high-dimensional data into actionable insights, backed by support from an expert team.
The clearest public pricing message is Omni 1000’s “$50 Proteome” value proposition, which is well suited for large cohorts or high-throughput experiments where cost control matters. For delivery, Nomic says data can be obtained within days, as fast as about one week, which is significantly better than traditional workflows that can take months. However, the site does not disclose minimum sample volumes, volume discounts, contract terms, payment methods, or specific pricing for Core/Flex, so procurement still requires contacting sales.
The strengths are large-scale detection, clear cost positioning, flexible panels, and end-to-end service, making it suitable for research teams that cannot build an in-house proteomics platform. Customer feedback also highlights its analytics suite and support team. The downside is the lack of enterprise software details: team permissions, audit logs, APIs, third-party integrations, data security compliance, and deployment options are not clearly specified. It feels more like a research testing service portal than a standard SaaS system that can be evaluated directly.
Nomic is suitable for drug discovery, immunology, translational medicine, PBMC secretome research, and large-scale protein biomarker screening teams. The main site does not clarify access from China, and cross-border sample shipping, data compliance, payment, and invoicing all need to be confirmed separately. If deployment in China is restricted, alternatives to compare include Olink, SomaLogic, Seer, and domestic life sciences testing providers, with the final choice depending on sample type, marker coverage, and turnaround time.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on nomic.bio official site.
nomic.bio is an Canada SaaS provider. TG4G tracks its product information, with monthly pricing from $50.00, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach nomic.bio directly.